Table 4.
Biomarkers Versus Imaging/Size
MRI Classification |
Distribution | Enhancement | No. of Patients |
Ki67 (%) |
CD68 (No.) |
CD34 (No.) |
ER Score |
MRI Size (mm) |
Pathologic Size (mm) |
Pathologic Density Score |
---|---|---|---|---|---|---|---|---|---|---|
Group 1 | Focal | All | 8 | |||||||
Mean | 22.3 | 24.8 | 67 | 3.5 | 22.1 | 15.4 | 1.8 | |||
SD | 18 | 11.3 | 35.6 | 3.3 | 24.1 | 4 | 0.7 | |||
Range | 5.3–55.2 | 8–45 | 27–140 | 0–8 | 4–77 | 9–20 | 1–3 | |||
Group 2 | Linear ductal | All | 7 | |||||||
Mean | 38.9 | 29 | 80.3 | 3.5 | 26.9 | 34.9 | 1.3 | |||
SD | 18 | 7.6 | 77.2 | 3 | 19.2 | 47.2 | 0.5 | |||
Range | 17.2–71 | 20–42 | 15–198 | 0–8 | 9–60 | 9–140 | 1–2 | |||
Group 3 | Segmental, regional, multiregional | Heterogeneous | 12 | |||||||
Mean | 24.1 | 29 | 69 | 4.4 | 49.3 | 21.9 | 1.7 | |||
SD | 16.2 | 16.3 | 35.4 | 2.5 | 25.1 | 16.3 | 0.8 | |||
Range | 0.9–53 | 13–73 | 21–122 | 0–8 | 18–93 | 4–50 | 1–3 | |||
Group 4 | Regional, multiregional | Clumped | 8 | |||||||
Mean | 26.3 | 62.8 | 50.8 | 2.1 | 71.6 | 41.9 | 2.3 | |||
SD | 11.9 | 49.5 | 28.5 | 3 | 40.1 | 31.8 | 0.5 | |||
Range | 8.1–43.2 | 20–145 | 28–117 | 0–7 | 36–158 | 14–90 | 2–3 | |||
Group 5 | Segmental | Clumped | 7 | |||||||
Mean | 30.5 | 63.5 | 64.9 | 3.4 | 56.6 | 43.7 | 2.9 | |||
SD | 13.6 | 51.9 | 22.6 | 3.3 | 9.5 | 12.8 | 0.4 | |||
Range | 15.4–47.6 | 14–166 | 17–87 | 0–7 | 40–70 | 24–60 | 2–3 | |||
Group 6 | Segmental, regional, multiregional | Homogeneous | 3 | |||||||
Mean | 29.4 | 99.7 | 70 | 1 | 71.7 | 53 | 2.3 | |||
SD | 14.5 | 61.2 | 12.5 | 1.7 | 47.6 | 35.6 | 0.6 | |||
Range | 14.5–43.4 | 34–155 | 60–84 | 0–3 | 21–114 | 19–90 | 2–3 |
Abbreviations: MRI, magnetic resonance imaging; ER, estrogen receptor; SD, standard deviation.